Sulforaphane, thus directly or indirectly activated AhR and protected against palmitic-acid induced in vitro model of NAFLD by downregulation of Srebp1c pathway [95]. The gene discussed is AHR; the disease is metabolic dysfunction-associated steatotic liver disease.